A new oral medication for obstructive sleep apnea, AD109, reduced breathing events by 44% in a six-month phase 3 trial. The drug combines...
New sleep apnea pill cuts breathing events by 44%
Breaking News
Boston has long been the biotech capital, but founders are leaving for California. Felix Wong's story highlights the draw of Silicon Valley's risk...
A 2024 cross-sectional study shows significant state-level differences in Type 1 diabetes incidence among those under 20, from 17.0 to 27.8 per...
Fashion
Food & Drinks
